1,224 reports of this reaction
4.1% of all AZACITIDINE FOR reports
#4 most reported adverse reaction
ACUTE MYELOID LEUKAEMIA is the #4 most commonly reported adverse reaction for AZACITIDINE FOR, manufactured by Accord Healthcare Inc.. There are 1,224 FDA adverse event reports linking AZACITIDINE FOR to ACUTE MYELOID LEUKAEMIA. This represents approximately 4.1% of all 29,877 adverse event reports for this drug.
Patients taking AZACITIDINE FOR who experience acute myeloid leukaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE MYELOID LEUKAEMIA is moderately reported among AZACITIDINE FOR users, representing a notable but not dominant share of adverse events.
In addition to acute myeloid leukaemia, the following adverse reactions have been reported for AZACITIDINE FOR:
The following drugs have also been linked to acute myeloid leukaemia in FDA adverse event reports:
ACUTE MYELOID LEUKAEMIA has been reported as an adverse event in 1,224 FDA reports for AZACITIDINE FOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE MYELOID LEUKAEMIA accounts for approximately 4.1% of all adverse event reports for AZACITIDINE FOR, making it a notable side effect.
If you experience acute myeloid leukaemia while taking AZACITIDINE FOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.